Patent details

301039 Product Name: Fostamatinib of een farmaceutisch aanvaardbaar zout van fostamatinib, of een hydraat, solvaat of N-oxide van fostamatinib of het farmaceutisch aanvaardbare zout van fostamatinib, in het bijzonder dinatriumfostamatinib eventueel in de vorm van een hydraat

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301039
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1856135
Status:
SPC in force
Application number:
301039
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/19/1405
Marketing Authorization Type:
EEA
Marketing Authorization Date:
13/01/2020
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
28/04/2020
First Marketing Authorization date:
13/01/2020
Grant date:
12/05/2020
Activation date:
19/01/2026
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
29/04/2020
SPC/SPC Extension Expiration Date:
18/01/2031
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
28/04/2020
 
 

 

Name:
Rigel Pharmaceuticals, Inc.
Address:
1180 Veterans Blvd., 94080, South San Francisco, California, United States of America (US)

Agent

Name:
ir. F.A. Geurts c.s.
From:
28/04/2020
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
03/26
Publication date:
21/01/2026
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
20/20
Publication date:
13/05/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
18/20
Publication date:
29/04/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
31/01/2027
Annual Fee Number:
22
Annual Fee Amount:
1800 Euro
Last Annual Payment Date:
29/12/2025
Last Annual Fee Paid Number:
21
Last Annual Fee Paid Amount:
1600 Euro
Payer:
Computer Packages Inc. (CPI)
Filing date Document type Document Description Number of pages File Type
12/05/2020 Front Page Front Page 1 PDF /2/2/0/6/4/0800546022/docs/301039_0_i2frontpage20200512121345896.pdf
12/05/2020 Certificate Certificate 1 PDF /2/2/0/6/4/0800546022/docs/301039_6_spcmedcertificate20200512121546047.pdf
12/05/2020 Outgoing Correspondence Decision grant 2 PDF /2/2/0/6/4/0800546022/docs/301039_9_343700l504a.pdf
29/04/2020 Outgoing Correspondence Confirmation receipt request 1 PDF /2/2/0/6/4/0800546022/docs/301039_2_341555l174.pdf
29/04/2020 Front Page Front Page 1 PDF /2/2/0/6/4/0800546022/docs/301039_4_i1frontpage20200429111723254.pdf
28/04/2020 SPC Documents Annex SPC 1 PDF /2/2/0/6/4/0800546022/docs/301039_1_supplprotectioncertificate20200428043524993.pdf
28/04/2020 SPC Documents Marketing Authorization SPC 3 PDF /2/2/0/6/4/0800546022/docs/301039_3_supplprotectioncertificate20200428043525053.pdf
28/04/2020 SPC Documents Summary of the characteristics of the product 20 PDF /2/2/0/6/4/0800546022/docs/301039_5_supplprotectioncertificate20200428043525115.pdf
28/04/2020 Application Form First filed application form 4 PDF /2/2/0/6/4/0800546022/docs/301039_7_applicationform20200428043524875.pdf
28/04/2020 SPC Documents Annex SPC 3 PDF /2/2/0/6/4/0800546022/docs/301039_8_supplprotectioncertificate20200428043525175.pdf